GVT
AZN icon

Genesee Valley Trust’s AstraZeneca AZN Stock Holding History

Genesee Valley Trust’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		$227K Buy
3,413
+70
+2% +$4.85K 0.09% 190
2017
Q4 		$232K Sell
3,343
-72
-2% -$4.86K 0.1% 188
2017
Q3 		$231K Hold
3,415
– – 0.09% 188
2017
Q2 		$233K Sell
3,415
-318
-9% -$20.8K 0.1% 187
2017
Q1 		$232 Buy
3,733
+65
+2% +$3.78K 0.16% 203
2016
Q4 		$200 Sell
3,668
-7,826
-68% -$444K 0.14% 215
2016
Q3 		$755K Sell
11,494
-4,493
-28% -$294K 0.46% 66
2016
Q2 		$965K Buy
15,987
+193
+1% +$11.2K 0.63% 46
2016
Q1 		$889K Sell
15,794
-20
-0.1% -$1.2K 0.6% 56
2015
Q4 		$1.07M Buy
15,814
+809
+5% +$53K 0.71% 35
2015
Q3 		$955K Buy
15,005
+2,666
+22% +$175K 0.64% 37
2015
Q2 		$786K Buy
12,339
+9,034
+273% +$619K 0.51% 50
2015
Q1 		$226K Sell
3,305
-80
-2% -$5.56K 0.14% 238
2014
Q4 		$238K Buy
3,385
+10
+0.3% +$716 0.15% 207
2014
Q3 		$241K Buy
3,375
+60
+2% +$4.39K 0.15% 232
2014
Q2 		$246K Sell
3,315
-2,365
-42% -$171K 0.15% 248
2014
Q1 		$369K Buy
5,680
+170
+3% +$11K 0.23% 124
2013
Q4 		$327K Sell
5,510
-55
-1% -$2.99K 0.22% 158
2013
Q3 		$289K Sell
5,565
-60
-1% -$3.01K 0.21% 167
2013
Q2 		$266K Buy
+5,625
New +$286K 0.21% 186

Other funds holding AZN

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
EIP
Epoch Investment Partners New York $16.5B AUM 24.3% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Genesee Valley Trust's AZN Position: Q1 2018 in Review

Genesee Valley Trust increased its AstraZeneca (AZN) stake by 2.1% in Q1 2018, buying an estimated $4.85K and bringing the position to 3,413 shares worth $227K. The position accounts for 0.09% of the portfolio, ranked #190.

Genesee Valley Trust first reported a position in AZN in Q2 2013 and has held it in 20 quarters since. The position peaked at $1.07M in Q4 2015. 518 funds tracked by Wall St. Rank hold AZN as of Q1 2018.

  • Genesee Valley Trust held 3,413 shares of AstraZeneca worth $227K as of Q1 2018.
  • Genesee Valley Trust bought 70 AstraZeneca shares in Q1 2018, an estimated $4.85K.
  • AstraZeneca made up 0.09% of Genesee Valley Trust's portfolio in Q1 2018, its #190 holding.
  • Genesee Valley Trust first reported a position in AstraZeneca in Q2 2013 and has held it in 20 quarters since.
  • Genesee Valley Trust's AstraZeneca position peaked at $1.07M in Q4 2015.
  • 518 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2018.

Based on Genesee Valley Trust's 13F filing for Q1 2018, filed 3 Apr 2018.